Ergocalciferol uses
Pro Research Analysisby 
Searched over 200M research papers for "ergocalciferol uses"
Uses of Ergocalciferol: A Comprehensive Overview
Ergocalciferol in Chronic Kidney Disease (CKD)
Treatment of Mineral and Bone Disorders in CKD
Ergocalciferol has been studied for its efficacy in managing mineral and bone disorders in patients with chronic kidney disease (CKD). A randomized controlled trial compared ergocalciferol with calcitriol in CKD patients at stages 3 to 5. The study found that ergocalciferol significantly increased 25-hydroxyvitamin D levels and had a similar long-term efficacy and safety profile as calcitriol in maintaining target levels of serum calcium, phosphorus, and intact parathyroid hormone .
Delaying Secondary Hyperparathyroidism in Children with CKD
In children with CKD stages 2-4, ergocalciferol supplementation was shown to delay the onset of secondary hyperparathyroidism. The study demonstrated that ergocalciferol effectively maintained normal 25-hydroxyvitamin D levels and significantly prolonged the time to development of hyperparathyroidism compared to placebo .
Microcirculatory Function in CKD
Ergocalciferol has also been explored for its effects on microcirculatory endothelial function in CKD patients with vitamin D deficiency. A study found that ergocalciferol improved endothelium-dependent microcirculatory vasodilatation and reduced tissue advanced glycation end products, suggesting enhanced endothelial function .
Ergocalciferol in Hemodialysis Patients
Vitamin D Deficiency in Hemodialysis
A clinical trial assessed the impact of ergocalciferol supplementation in hemodialysis patients with vitamin D deficiency. The results indicated that while ergocalciferol significantly increased serum 25-hydroxyvitamin D levels, it did not affect epoetin utilization or other secondary biochemical and clinical outcomes over six months .
Ergocalciferol in Type 1 Diabetes
Immunomodulatory Effects in New-Onset Type 1 Diabetes
Ergocalciferol has been investigated for its potential immunomodulatory effects in youth with newly diagnosed type 1 diabetes. The study found that ergocalciferol supplementation significantly reduced serum tumor necrosis factor-alpha (TNF-α) levels and blunted the temporal trends for rising glycated hemoglobin A1c (HbA1c) and insulin dose-adjusted A1c, suggesting a protective effect on residual β-cell function .
Ergocalciferol in Cystic Fibrosis
High-Dose Supplementation for Vitamin D Deficiency
In children and young adults with cystic fibrosis, a very high-dose ergocalciferol regimen (700,000 IU over 14 days) was found to be effective in achieving therapeutic vitamin D levels. The study reported a significant increase in 25-hydroxyvitamin D levels without any adverse effects, indicating the regimen's safety and efficacy .
Ergocalciferol in Postmenopausal Women
Addressing Vitamin D Inadequacy
A trial in institutionalized postmenopausal women compared standard and high doses of ergocalciferol for treating vitamin D inadequacy. The high-dose group achieved more optimal 25-hydroxyvitamin D levels than the standard dose group, suggesting that higher doses of ergocalciferol are more effective in correcting severe vitamin D deficiency .
Ergocalciferol in Secondary Hyperparathyroidism
Comparison with Paricalcitol
A study comparing ergocalciferol with paricalcitol for treating secondary hyperparathyroidism in CKD patients found that paricalcitol was more effective in reducing parathyroid hormone levels. However, ergocalciferol significantly increased serum 25-hydroxyvitamin D levels .
Ergocalciferol in Leukemia
Induction of Apoptosis in Leukemia Cells
Research has shown that ergocalciferol can induce apoptosis in human leukemia cells through mechanisms involving reactive oxygen species generation, glutathione depletion, and caspase activation. This suggests potential anticancer properties of ergocalciferol .
Conclusion
Ergocalciferol is a versatile form of vitamin D2 with multiple therapeutic uses across various medical conditions. It is effective in managing mineral and bone disorders in CKD, delaying secondary hyperparathyroidism, improving endothelial function, and addressing vitamin D deficiency in different patient populations. Additionally, it shows promise in immunomodulation in type 1 diabetes and potential anticancer activity in leukemia.
Sources and full results
Most relevant research papers on this topic